XML 23 R10.htm IDEA: XBRL DOCUMENT
v3.23.1

Supplemental Financial Data | 3 Months Ended
--- | ---
Mar. 31, 2023
Supplemental Financial Data [Abstract] |
Supplemental Financial Data [Text Block] | 3. Supplemental Financial Data Inventories Our inventory consisted of the following (in thousands):
|  | March 31, 2023 |  |  | December 31, 2022 |
Raw materials: |  |  |  |  |  |
Raw materials - clinical |  | $ | 17,356 |  |  | $ | 17,061 |
Raw materials - commercial |  |  | 2,786 |  |  |  | 2,699 |
Total raw materials |  |  | 20,142 |  |  |  | 19,760 |
Work in process |  |  | 1,840 |  |  |  | 2,109 |
Finished goods |  |  | 218 |  |  |  | 164 |
Total inventory |  | $ | 22,200 |  |  | $ | 22,033 |
Accrued Liabilities Our accrued liabilities consisted of the following (in thousands):
|  | March 31, 2023 |  |  | December 31, 2022 |
Clinical development expenses |  | $ | 85,694 |  |  | $ | 116,460 |
In-licensing expenses |  |  | 12,704 |  |  |  | 7,945 |
Commercial expenses |  |  | 4,704 |  |  |  | 3,498 |
Other miscellaneous expenses |  |  | 9,600 |  |  |  | 12,198 |
Total accrued liabilities |  | $ | 112,702 |  |  | $ | 140,101 |

X
- References No definition available. + Details
Name: | ions_SupplementalFinancialDataAbstract
Namespace Prefix: | ions_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI https://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration